LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 27.84 | 770.25 | 2642 | 2833 | 0.9323 | 0.9268 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 30.06 | 770.25 | 3034 | 3106 | 0.9768 | 0.9768 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 30.06 | 770.25 | 2919 | 3106 | 0.9398 | 0.9392 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 32.28 | 770.25 | 3274 | 3392 | 0.9650 | 0.9669 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 32.28 | 770.25 | 3201 | 3392 | 0.9435 | 0.9463 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 34.50 | 770.25 | 3576 | 3712 | 0.9634 | 0.9674 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 34.50 | 770.25 | 3453 | 3712 | 0.9302 | 0.9373 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 36.73 | 770.25 | 3995 | 4086 | 0.9777 | 0.9814 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 36.73 | 770.25 | 3908 | 4086 | 0.9564 | 0.9633 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 38.95 | 770.25 | 4406 | 4543 | 0.9697 | 0.9761 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 38.95 | 770.25 | 4270 | 4543 | 0.9397 | 0.9520 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.17 | 770.25 | 4881 | 5010 | 0.9741 | 0.9807 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 41.17 | 770.25 | 4649 | 5010 | 0.9278 | 0.9453 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.39 | 770.25 | 5296 | 5404 | 0.9800 | 0.9856 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 43.39 | 770.25 | 5020 | 5404 | 0.9289 | 0.9482 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.61 | 770.25 | 5685 | 5813 | 0.9780 | 0.9848 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 45.61 | 770.25 | 5557 | 5813 | 0.9560 | 0.9694 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.83 | 770.25 | 6126 | 6223 | 0.9843 | 0.9896 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.83 | 770.25 | 5907 | 6223 | 0.9491 | 0.9657 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.05 | 770.25 | 6587 | 6629 | 0.9936 | 0.9959 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.05 | 770.25 | 6359 | 6629 | 0.9592 | 0.9734 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.27 | 770.25 | 7095 | 7058 | 1.0051 | 1.0032 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.27 | 770.25 | 6863 | 7058 | 0.9723 | 0.9825 | MN20160304_L02 | I21 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.49 | 770.25 | 7575 | 7555 | 1.0026 | 1.0016 | MN20160304_L02 | D17 |
MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.49 | 770.25 | 7377 | 7555 | 0.9764 | 0.9855 | MN20160304_L02 | I21 |